Furthermore, endocan can bind to LFA-1 and thereby inhibit its interactions with ICAM1/2 [2,23,31], and both primary AML [61,62] and ALL [63,64,65] cells can express LFA-1 as well as ICAMs. Here, ITGAL is linked to acute lymphoblastic leukemia.